Search by Drug Name or NDC

    NDC 50383-0261-61 Dorzolamide Hydrochloride and Timolol Maleate 20; 5 mg/mL; mg/mL Details

    Dorzolamide Hydrochloride and Timolol Maleate 20; 5 mg/mL; mg/mL

    Dorzolamide Hydrochloride and Timolol Maleate is a OPHTHALMIC SOLUTION/ DROPS in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Akorn. The primary component is DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE.

    Product Information

    NDC 50383-0261
    Product ID 50383-261_7265e092-2ed5-4b1a-83e8-e3bd2cfb10f4
    Associated GPIs 86259902202060
    GCN Sequence Number 061877
    GCN Sequence Number Description dorzolamide/timolol/PF DROPERETTE 2 %-0.5 % OPHTHALMIC
    HIC3 Q6G
    HIC3 Description MIOTICS AND OTHER INTRAOCULAR PRESSURE REDUCERS
    GCN 97662
    HICL Sequence Number 034283
    HICL Sequence Number Description DORZOLAMIDE HCL/TIMOLOL MALEATE/PF
    Brand/Generic Generic
    Proprietary Name Dorzolamide Hydrochloride and Timolol Maleate
    Proprietary Name Suffix n/a
    Non-Proprietary Name Dorzolamide Hydrochloride and Timolol Maleate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form SOLUTION/ DROPS
    Route OPHTHALMIC
    Active Ingredient Strength 20; 5
    Active Ingredient Units mg/mL; mg/mL
    Substance Name DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE
    Labeler Name Akorn
    Pharmaceutical Class Adrenergic beta-Antagonists [MoA], Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], beta-Adrenergic Blocker [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA202667
    Listing Certified Through 2024-12-31

    Package

    NDC 50383-0261-61 (50383026161)

    NDC Package Code 50383-261-61
    Billing NDC 50383026161
    Package 4 POUCH in 1 CARTON (50383-261-61) / 15 VIAL, SINGLE-USE in 1 POUCH / .2 mL in 1 VIAL, SINGLE-USE
    Marketing Start Date 2019-02-01
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 1.7509
    Pricing Unit EA
    Effective Date 2022-11-23
    NDC Description DORZOLAMIDE-TIMOLOL 2%-0.5%
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1, 5, 6
    Classification for Rate Setting G
    As of Date 2022-11-23
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis

    Standard Product Labeling (SPL)/Prescribing Information SPL 4e90c721-21e8-46ea-ab49-19f535bf7202 Details

    Revised: 5/2022